Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay

Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, Thomas Sonnweber, Wolfgang Mayer, Harald Schennach, Judith Loeffler-Ragg, Rosa Bellmann-Weiler, Ivan Tancevski, Günter Weiss, Markus Anliker, Andrea Griesmacher, Gregor Hoermann
doi: https://doi.org/10.1101/2020.11.27.20239590

Article usage

Article usage: November 2020 to December 2024

AbstractFullPdf
Nov 2020300052
Dec 202054233469
Jan 202115274183
Feb 20211497245
Mar 20211009437
Apr 20211098431
May 20211005725
Jun 2021674918
Jul 2021587014
Aug 2021556023
Sep 2021374022
Oct 2021553131
Nov 2021514338
Dec 2021311912
Jan 2022292914
Feb 20221797
Mar 202218205
Apr 202224135
May 2022211014
Jun 20222155
Jul 20221757
Aug 202220411
Sep 202230511
Oct 202222411
Nov 20221504
Dec 20221549
Jan 202318810
Feb 2023151110
Mar 20231302
Apr 202326613
May 202313210
Jun 20231046
Jul 20231217
Aug 2023201317
Sep 20231469
Oct 202315310
Nov 20232398
Dec 20231158
Jan 20242333
Feb 20241639
Mar 202413211
Apr 2024181016
May 20241277
Jun 2024954
Jul 20241208
Aug 2024341313
Sep 20241336
Oct 20241887
Nov 202420518
Dec 20241232
Back to top
Posted November 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, Thomas Sonnweber, Wolfgang Mayer, Harald Schennach, Judith Loeffler-Ragg, Rosa Bellmann-Weiler, Ivan Tancevski, Günter Weiss, Markus Anliker, Andrea Griesmacher, Gregor Hoermann
medRxiv 2020.11.27.20239590; doi: https://doi.org/10.1101/2020.11.27.20239590
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area